Cresco Labs Inc.

CRLBF • Drug Manufacturers - Specialty & Generic

$0.78

▲ +0.04 (+5.23%)

Precio actual

ResultadosÚltimo reporte: 31 mar 2026

PERFIL EQUILIBRADONeutralConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Perfil mixto. La empresa no es necesariamente mala, pero la valoración, el crecimiento o el balance todavía no justifican una señal más fuerte.

Capitalización

$284.10M

Crecimiento

—

Flujo de caja

3/5

Tendencia

Mostly stable

Evidencia

Flujo de caja libre positivo · 0.11Liquidez saludable · 2.59Rentabilidad débil

Datos financieros hasta: 31 mar 2026, 12:00 a.m. UTCÚltima actualización de earnings: 8 may 2026, 12:00 a.m. UTCÚltima actualización del perfil: 5 ago 2026, 2:27 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$0.78

Change5.23%

Shares Out364.23M

Market Cap$284.10M

Enterprise Value$663.80M

52W Range0.43 - 2.30

Beta1.71

P/E-2.08

P/S0.44

P/B0.84

P/FCF-88.23

EV/Sales1.03

Price$0.78

Change5.23%

Shares Out364.23M

Market Cap$284.10M

Enterprise Value$663.80M

52W Range0.43 - 2.30

Beta1.71

P/E-2.08

P/S0.44

P/B0.84

P/FCF-88.23

EV/Sales1.03

EV/EBITDA6.13

EV/FCF-206.14

Earnings Yield-48.08%

FCF Yield-1.13%

Dividend Yield0.00%

Gross Margin46.41%

Oper. Margin11.76%

Profit Margin-21.35%

Debt/Eq1.72

Current Ratio2.59

Quick Ratio2.59

Target$5.50

Target Upside605.13%

Target Median$5.50

Target Range2.50 - 8.50

Volume439.10K

Avg Volume922.10K

EPS Surprise-0.01

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

33/100

Fortaleza financiera

Deuda, caja, estabilidad

61/100

Potencial de crecimiento

Ingresos y expansión

58/100

Atractivo del precio

Barata o cara hoy

92/100

Por qué este puntaje▼

Flujo de caja libre positivo · 0.11Liquidez saludable · 2.59Rentabilidad débil

Analyst view

Analyst sentiment and price target

CRLBF

Analyst sentiment

Based on 7 analyst votes · 2026-09-05

79/100

Bullish

Hold

Bearish

Precio objetivo

2026-06-06

Bajo

$2.50

Promedio

$5.50

Mediana

$5.50

Alto

$8.50

Resumen de la compañía

IPO: 12/3/2018

Industria: Drug Manufacturers - Specialty & Generic

P/B i: 0.84

Deuda / Patrimonio i: 1.72

Margen operativo: 11.76%

Margen neto: -21.35%

ROE i: -

ROIC: -

Salud financiera

Puntaje12 / 20

Deuda / Patrimonio: 1.72

Ratio corriente: 2.59

Ratio rápido: 2.59

Estado: Good

🧾

No hay actividad interna

No hay transacciones internas recientes disponibles.

Sobre la compañía

Cresco Labs Inc.

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand, as well as cannabis products under the Reserve brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections, fruit-forward gummies, hard sweets, and taffy under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. As of January 27, 2022, it owned and operated 48 dispensaries. The company was founded in 2013 and is headquartered in Chicago, Illinois.

Fuente - Link

Competidores

ABTI AGYTF AVCTF BHHKF HLOSF HUMDF KHTRF NWBO PTCHF VRNOF

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

Ultimas Noticias

Cannabis Stock CRLBF Surges 10% in a Month: Time to Buy or Sell?

Cresco's 10% monthly rally reflects stronger revenues, organic growth and margins, but competition and normalization risks cloud the outlook.

Zacks Investment Research

Cresco Labs Acquires Nine Pennsylvania Dispensaries in Accretive Transaction to Strengthen Market Leadership

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”) today announced the closing of its acquisition of 100% of the outstanding equity interests in PharmaCann Penn, LLC (“PharmaCann”) for an aggregate consideration of US$50 million (the “Transaction”). The Transaction consists of nine operational retail medical marijuana dispensaries in Pennsylvania, advancing Cresco's leadership position in the second-largest medical marijuana market, wh.

Business Wire

3 Marijuana Stocks For Investors To Consider

What will help marijuana stock investors trade more, even in the midst of laws changing in the USA? It is no secret that nothing has moved pot stocks more than news of global reform or regulatory matters. For the US, what happens at the federal level has moved the needle the most, with the recent passing of legislation to reclassify cannabis to Schedule 3.

MarijuanaStocks

Cresco Labs Inc. (CRLBF) Q2 2026 Earnings Call Transcript

Seeking Alpha

Cresco Labs Inc. (CRLBF) Q2 Earnings and Revenues Top Estimates

Cresco Labs Inc. (CRLBF) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to a loss of $0.05 per share a year ago.

Zacks Investment Research

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2026-05-08	-0.03	-0.04	-0.01
2026-03-05	-0.01497	-0.24	-0.22503
2025-11-05	-0.03	-0.05	-0.02
2025-08-07	-0.04	-0.05	-0.01
2025-05-30	-0.03	-0.04	-0.01
2025-03-12	-0.01	-0.01	0
2024-11-08	-0.00348	-0.02	-0.01652
2024-08-08	-0.01	-0.16	-0.15
2024-05-15	-0.01909	-0.02	-0.00091
2024-03-13	-0.02	0.01	0.03
2023-11-15	-0.04	-0.04	0
2023-08-16	-0.04	-0.05	-0.01